Trial NCT05510427

View at ClinicalTrials.gov 
Org. Study IDs: 2021-0149
Secondary IDs: NCI-2022-06868

Last trial update was posted on 2023-08-15

MeSH Interventions

Atezolizumab Bevacizumab Infigratinib

MeSH Conditions

Cholangiocarcinoma

Other Conditions

Liver Cancer

Stopping Reasons

Per PI's request

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID